Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.

about

Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues.Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents

P2860

Q51731233-DF9F6912-D1DE-4A68-8AEB-CBB629437DAB Q57062310-07B740EE-C4A0-4C97-8BAE-149AC9C1E9EB

P2860

Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.

Item

http://www.wikidata.org/entity/Q49308131

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Synthesis and characterization ...... earing quinoxalindione moiety.

@en

Synthesis and characterization ...... earing quinoxalindione moiety.

@nl

type

Item

label

Synthesis and characterization ...... earing quinoxalindione moiety.

@en

Synthesis and characterization ...... earing quinoxalindione moiety.

@nl

prefLabel

Synthesis and characterization ...... earing quinoxalindione moiety.

@en

Synthesis and characterization ...... earing quinoxalindione moiety.

@nl

P1476

Synthesis and characterization ...... bearing quinoxalindione moiety

@en

P2093

Amirhossein Sakhteman

http://www.w3.org/2001/XMLSchema#string

Farshid Hassanzadeh

http://www.w3.org/2001/XMLSchema#string

Ghadamali Khodarahmi

http://www.w3.org/2001/XMLSchema#string

Mahboubeh Rostami

http://www.w3.org/2001/XMLSchema#string

Mahmoud Mirzaei

http://www.w3.org/2001/XMLSchema#string

Sedighe Sadeghian-Rizi

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib: a review of its use in advanced hepatocellular carcinoma

Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar lead.

Lenvima (Lenvatinib), a Multireceptor Tyrosine Kinase Inhibitor, Approved by the FDA for the Treatment of Patients with Differentiated Thyroid Cancer.

Sorafenib for the treatment of advanced renal cell carcinoma.

Tivozanib for the treatment of metastatic renal cancer.

Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit.

Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.

Design, synthesis and biological activities of thiourea containing sorafenib analogs as antitumor agents.

New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell line.

A quantitative structure-activity relationship (QSAR) study of some diaryl urea derivatives of B-RAF inhibitors.

P304

82-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1735-5362.220971

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ali Jahanian-Najafabadi

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29387115

http://www.w3.org/2001/XMLSchema#string

P932

5772085

http://www.w3.org/2001/XMLSchema#string

Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.

about

P2860

P2860

Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932